NEW YORK, June 25, 2025--(BUSINESS WIRE)--Ferric, Inc., a leader in cutting-edge power conversion solutions, announced its collaboration with Marvell Technology, Inc. (NASDAQ: MRVL) to develop ...

Ferric carboxymaltose therapy reduces symptoms and improves quality of life in patients who have heart failure with a reduced ejection fraction and iron deficiency. Additional evidence about the ...

Power conversion specialist Ferric has teamed with Marvell Technology to tackle one of the biggest bottlenecks facing AI and cloud infrastructure: efficient power delivery to increasingly hungry ...

The Fe1766 integrated voltage regulator (IVR) on a US dime – delivering 160 A in a compact 4.2 × 8 x 1 mm package with industry-leading 4.5 A/mm² current density Fe1766 delivers an unprecedented 160 A ...

NEW YORK--(BUSINESS WIRE)--Ferric, a leader in cutting-edge power conversion solutions, today announced the appointment of Sagar Pushpala to its Board of Directors, effective immediately. Pushpala ...

Ferric carboxymaltose has become the first form of intravenous iron replacement to earn a US Food and Drug Administration indication for heart failure, the manufacturer announced today. Injectafer ...

Please provide your email address to receive an email when new articles are posted on . Ferric citrate may be more effective than ferrous sulfate for treating iron deficiency in patients with chronic ...

Fe1766 delivers an unprecedented 160 A in the industry’s smallest IVR footprint, redefining chip-level and system-level power delivery for the AI era “This launch represents a major milestone in ...